Actavis Growing in Double Digits in Bulgaria

Actavis Group, the international generic pharmaceuticals company, announced that Actavis is growing in double digits in Bulgaria through its broad product portfolio, reaching 10.65 percent in the first half with over EUR 23.1 million in sales of its own label products.
FOCUS News Agency